Coherus BioSciences, Inc.
CHRS
$0.9103
$0.104112.91%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/1/2025
-
The Fly
4/1/2025
-
Globe Newswire
3/28/2025
-
Simply Wall St
3/25/2025
-
Globe Newswire
3/24/2025
-
Simply Wall St
3/12/2025
-
Insider Monkey
3/12/2025
-
MarketBeat
3/12/2025
-
Simply Wall St
3/12/2025
-
TipRanks Financial Blog
3/11/2025
-
MarketBeat
3/11/2025
-
GuruFocus
3/11/2025
-
GuruFocus
3/11/2025
-
SeekingAlpha
3/11/2025
-
Seeking Alpha: Transcripts
3/10/2025
-
GuruFocus
3/10/2025
-
The Fly
3/10/2025
-
The Fly
3/10/2025
-
Globe Newswire
3/7/2025
-
GuruFocus
3/4/2025
-
Simply Wall St
3/3/2025
-
Globe Newswire
2/24/2025
-
Globe Newswire
2/14/2025
-
GuruFocus
2/5/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 649 3530
Address
333 Twin Dolphin Drive
Redwood City, CA 94065
Redwood City, CA 94065
Country
Year Founded
Business Description
Sector
Coherus BioSciences, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar...
more
